Northern Private Capital (NPC)

MicroSintesis Inc., founded in 2016 and based in Charlottetown, Prince Edward Island, Canada, specializes in the development of probiotic products aimed at enhancing animal health. The company produces YGIA for dogs and NUVIO for swine, utilizing innovative technology that harnesses natural bioactive molecules from probiotics. This approach significantly reduces the expression of virulence genes in various pathogenic bacteria, offering an alternative method to lower antibiotic usage and combat antibiotic resistance. By focusing on microbiome therapies, MicroSintesis has patented bio-peptide signal molecules that help rebalance gut bacteria populations in both livestock and companion animals, ultimately promoting improved gut health and overall animal well-being.